2019 ISPN共识指南:发展中国家溶血性尿毒综合征

2019-04-15 肾脏病相关专家小组(统称) Pediatr Nephrol. 2019 Apr 15.

溶血性尿毒综合征(HUS)是导致儿童急性肾损伤的主要原因,尽管国际指南强调进行全面评估并应用应用依库珠单抗进行治疗,但在发展中国家该病的诊断和治疗通常受限。本文主要针对发展中国家溶血性尿毒综合征的诊断和管理提供指导建议。

中文标题:

2019 ISPN共识指南:发展中国家溶血性尿毒综合征

英文标题:

Hemolytic uremic syndrome in a developing country: Consensus guidelines.

发布日期:

2019-04-15

简要介绍:

溶血性尿毒综合征(HUS)是导致儿童急性肾损伤的主要原因,尽管国际指南强调进行全面评估并应用应用依库珠单抗进行治疗,但在发展中国家该病的诊断和治疗通常受限。本文主要针对发展中国家溶血性尿毒综合征的诊断和管理提供指导建议。 

拓展指南:肾损伤相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2019 ISPN共识指南:发展中国家溶血性尿毒综合征)] GetToolGuiderByIdResponse(projectId=1, id=dd33f1c001e336ff, title=2019 ISPN共识指南:发展中国家溶血性尿毒综合征, enTitle=Hemolytic uremic syndrome in a developing country: Consensus guidelines., guiderFrom=Pediatr Nephrol. 2019 Apr 15., authorId=null, author=, summary=溶血性尿毒综合征(HUS)是导致儿童急性肾损伤的主要原因,尽管国际指南强调进行全面评估并应用应用依库珠单抗进行治疗,但在发展中国家该病的诊断和治疗通常受限。本文主要针对发展中国家溶血性尿毒综合征的诊断和管理提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=283, associationName=肾脏病相关专家小组(统称), associationIntro=本制定者非特指某个专家小组。, copyright=0, guiderPublishedTime=Mon Apr 15 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<div>溶血性尿毒综合征(HUS)是导致儿童急性肾损伤的主要原因,尽管国际指南强调进行全面评估并应用应用依库珠单抗进行治疗,但在发展中国家该病的诊断和治疗通常受限。本文主要针对发展中国家溶血性尿毒综合征的诊断和管理提供指导建议。 </div> <div><br> </div>拓展指南:<strong>与<font color=red>肾损伤</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=70ae01c001523032" title="多发性骨髓瘤肾损伤诊治专家共识" target=_blank>多发性骨髓瘤肾损伤诊治专家共识</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=31a961c00151a3d5" title="2017 共识指南:应用羧肽酶治疗高剂量甲氨蝶呤引起急性肾损伤以及甲氨蝶呤清除延迟患者" target=_blank>2017 共识指南:应用羧肽酶治疗高剂量甲氨蝶呤引起急性肾损伤以及甲氨蝶呤清除延迟患者</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=f7c821c001a28889" title="中国肝移植受者肾损伤管理专家共识(2017版)" target=_blank>中国肝移植受者肾损伤管理专家共识(2017版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=be5481c001385813" title="2016年日本药物相关性肾损伤临床实践指南(中文翻译版)" target=_blank>2016年日本药物相关性肾损伤临床实践指南(中文翻译版)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=c8f2c1c0013632c6" title="伴有肾损伤及其高危风险的慢性乙型肝炎患者抗病毒治疗专家共识" target=_blank>伴有肾损伤及其高危风险的慢性乙型肝炎患者抗病毒治疗专家共识</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E8%82%BE%E6%8D%9F%E4%BC%A4" target=_blank>有关肾损伤更多指南</a></ul>, tagList=[TagDto(tagId=89424, tagName=发展中国家溶), TagDto(tagId=89425, tagName=血性尿毒综合征)], categoryList=[CategoryDto(categoryId=14, categoryName=肾内科, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4123, appHits=227, showAppHits=7, pcHits=2929, showPcHits=1732, likes=93, shares=8, comments=3, approvalStatus=1, publishedTime=Sun May 05 23:25:30 CST 2019, publishedTimeString=2019-04-15, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun May 05 23:25:30 CST 2019, updatedBy=null, updatedName=null, updatedTime=Tue Jan 02 05:03:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2019 ISPN共识指南:发展中国家溶血性尿毒综合征)])
2019 ISPN共识指南:发展中国家溶血性尿毒综合征
下载请点击:
评论区 (2)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=903755, encodeId=3fb5903e55ef, content=good~非常好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/BZtjzYlPGFAU5DepL4ElVLeicdbMcpRDIP4ibwkAUz94U5IaIPiaKWNlDU6EAphyBm37VKdJyhDVksCY3bXTqngIw/132, createdBy=7c765155950, createdName=ms129555082069295, createdTime=Tue Dec 01 08:22:54 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365878, encodeId=26493658e81d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Tue May 07 17:46:00 CST 2019, time=2019-05-07, status=1, ipAttribution=)]
    2020-12-01 ms129555082069295

    good~非常好👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=903755, encodeId=3fb5903e55ef, content=good~非常好👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/BZtjzYlPGFAU5DepL4ElVLeicdbMcpRDIP4ibwkAUz94U5IaIPiaKWNlDU6EAphyBm37VKdJyhDVksCY3bXTqngIw/132, createdBy=7c765155950, createdName=ms129555082069295, createdTime=Tue Dec 01 08:22:54 CST 2020, time=2020-12-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=365878, encodeId=26493658e81d, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=82, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/2EVCwc9WmQS6ec99H2TX8ejmR40xYjwrIcrqjAnibV36aicL1sLxc21rhpZnqTOxk33HP44iayEwo6qYXqgZvdRtA/132, createdBy=d0d01573846, createdName=329523732, createdTime=Tue May 07 17:46:00 CST 2019, time=2019-05-07, status=1, ipAttribution=)]
    2019-05-07 329523732

    不错

    0